Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Physical Review Letters|October 25, 2025
Precision Mass Measurements around ^{84}Mo Rule Out ZrNb Cycle Formation in the Rapid Proton-Capture Process at Type I X-Ray BurstsS Kimura, M Wada, C Y Fu, et al.
Physical Review Letters|June 9, 2023
First Direct Measurement Constraining the ^{34}Ar(α,p)^{37}K Reaction Cross Section for Mixed Hydrogen and Helium Burning in Accreting Neutron StarsJ Browne, K A Chipps, Konrad Schmidt, et al.
Physical Review Letters|July 12, 2014
β+ Gamow-Teller transition strengths from 46Ti and stellar electron-capture ratesS Noji, R G T Zegers, Sam M Austin, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell LymphomaAustin D Newsam, Bachisio Ziccheddu, Venu Venkatarame Gowda Saralamma, et al.
Physical Review Letters|January 31, 2015
Mass measurements demonstrate a strong N=28 shell gap in argonZ Meisel, S George, S Ahn, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2015
Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and overG Armbrecht, D Felsenberg, M Ganswindt, et al.
Physical Review Letters|November 10, 2015
Mass Measurement of 56Sc Reveals a Small A = 56 Odd-Even Mass Staggering, Implying a Cooler Accreted Neutron Star CrustZ Meisel, S George, S Ahn, et al.
Blood|October 15, 2021
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomasAlison J Moskowitz, Paola Ghione, Eric Jacobsen, et al.
Physical Review Letters|July 13, 2019
Constraining the Neutron Star Compactness: Extraction of the ^{23}Al(p,γ) Reaction Rate for the rp ProcessC Wolf, C Langer, F Montes, et al.
Blood Advances|April 7, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutionsAjay Major, Jovian Yu, Navika Shukla, et al.
Pageof 30